journal article·2014-06

Sensitive Detection of Human Insulin Using a Designed Combined Pore Approach

Chang Lei, Owen Noonan, Siddharth Jambhrunkar, Kun Qian, Chun Xu, Jun Zhang, Amanda Nouwens, Chengzhong Yu

Small· Volume 10· Issue 12
Publisher page

Abstract

A unique combined pore approach to the sensitive detection of human insulin is developed. Through a systematic study to understand the impact of pore size and surface chemistry of nanoporous materials on their enrichment and purification performance, the advantages of selected porous materials are integrated to enhance detection sensitivity in a unified two‐step process. In the first purification step, a rationally designed large pore material (ca. 100 nm in diameter) is chosen to repel the interferences from nontarget molecules. In the second enrichment step, a hydrophobically modified mesoporous material with a pore size of 5 nm is selected to enrich insulin molecules. A low detection limit of 0.05 ng mL−1 in artificial urine is achieved by this advanced approach, similar to most antibody‐based analysis protocols. This designer approach is efficient and low cost, and thus has great potential in the sensitive detection of biomolecules in complex biological systems.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Electrochemical sensors and biosensors · Nanopore and Nanochannel Transport Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Australian Institute for Bioengineering and Nanotechnology The University of Queensland Brisbane QLD 4072 Australia

References (33)

Show source-provided references
1. 10.2217/bmm.11.2610.2217/bmm.11.26 ↗
2. 10.1074/mcp.R200007-MCP20010.1074/mcp.R200007-MCP200 ↗
3. 10.1002/pmic.20050053510.1002/pmic.200500535 ↗
4. 10.1021/ac035217110.1021/ac0352171 ↗
5. 10.1002/anie.20046074110.1002/anie.200460741 ↗
6. 10.1677/joe.0.170001310.1677/joe.0.1700013 ↗
7. 10.1021/ac052095z10.1021/ac052095z ↗
8. 10.1002/mas.2015410.1002/mas.20154 ↗
9. Thevis M. · 2010 · 209
10. 10.1021/ac050066i10.1021/ac050066i ↗
11. Chevenne D. · Diabetes Metab. · 1999 · 25 · 459
12. 10.1016/j.ghir.2011.12.00510.1016/j.ghir.2011.12.005 ↗
13. 10.1021/cm103704s10.1021/cm103704s ↗
14. 10.1002/smll.20110177010.1002/smll.201101770 ↗
15. Qin H. Q. · Angew. Chem. Int. Ed. · 2011 · 50 · 2218
16. 10.1002/anie.20060391710.1002/anie.200603917 ↗
17. 10.1039/c3ra41332b10.1039/c3ra41332b ↗
18. 10.1021/cm103704s10.1021/cm103704s ↗
19. 10.1002/rcm.481010.1002/rcm.4810 ↗
20. Lei C. · Nanoscale · 2013 · 5 · 2033
21. Pujia A. · Int. J. Nanomed. · 2010 · 5 · 100510.2147/IJN.S12865 ↗
22. 10.1021/jp972788m10.1021/jp972788m ↗
23. 10.1021/ac980943310.1021/ac9809433 ↗
24. 10.1021/bi96029210.1021/bi960292 ↗
25. 10.1007/s00726-008-0159-x10.1007/s00726-008-0159-x ↗
26. 10.1016/j.chroma.2010.12.05210.1016/j.chroma.2010.12.052 ↗
27. 10.1007/s11419-012-0142-910.1007/s11419-012-0142-9 ↗
28. 10.1021/ac900550q10.1021/ac900550q ↗
29. 10.1021/nn900739z10.1021/nn900739z ↗
30. 10.1021/ja061904910.1021/ja0619049 ↗
31. 10.1021/ja402463h10.1021/ja402463h ↗
32. 10.1021/cm901999n10.1021/cm901999n ↗
33. 10.1021/ja066707o10.1021/ja066707o ↗